Feedback / Questions
aleglitazar (R1439) - Roche
Investor Day
(Roche)
-
Sep 5, 2012 -
"Lowering TG/HDL ratio was associated with a beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients"
P3 data
•
Diabetes
http://www.larvolonline.com/tlg/ccdb/RocheInvestorDay(3)Sep052012.pdf
Sep 5, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
(IR 8)